Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis

The farnesoid X receptor (FXR), an endogenous sensor for bile acids, regulates a program of genes involved in bile acid biosynthesis, conjugation, and transport. Cholestatic liver diseases are a group of immunologically and genetically mediated disorders in which accumulation of endogenous bile acids plays a role in the disease progression and symptoms. Here, we describe the effect of 6-ethyl chenodeoxycholic acid (6-ECDCA or INT-747), a semisynthetic bile acid derivative and potent FXR ligand, in a model of cholestasis induced by 5-day administration of 17α-ethynylestradiol (E217α) to rats. The exposure of rat hepatocytes to 1 μM 6-ECDCA caused a 3- to 5-fold induction of small heterodimer partner (Shp) and bile salt export pump (bsep) mRNA and 70 to 80% reduction of cholesterol 7α-hydroxylase (cyp7a1), oxysterol 12β-hydroxylase (cyp8b1), and Na+/taurocholate cotransporting peptide (ntcp). In vivo administration of 6-ECDCA protects against cholestasis induced by E217α. Thus, 6-ECDCA reverted bile flow impairment induced by E217α, reduced secretion of cholic acid and deoxycholic acid, but increased muricholic acid and chenodeoxycholic acid secretion. In vivo administration of 6-ECDCA increased liver expression of Shp, bsep, multidrug resistance-associated protein-2, and multidrug resistance protein-2, whereas it reduced cyp7a1 and cyp8b1 and ntcp mRNA. These changes were reproduced by GW4064, a synthetic FXR ligand. In conclusion, by demonstrating that 6-ECDCA protects against E217α cholestasis, our data support the notion that development of potent FXR ligands might represent a new approach for the treatment of cholestatic disorders.

[1]  J. Boyer,et al.  Molecular pathogenesis of cholestasis. , 2012, The New England journal of medicine.

[2]  A. Morelli,et al.  The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.

[3]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[4]  M. Evans,et al.  Estrogen Receptor (cid:1) Regulates Expression of the Orphan Receptor Small Heterodimer Partner* □ S , 2003 .

[5]  S. Kliewer,et al.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.

[6]  G. Costantino,et al.  Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). , 2003, Bioorganic & medicinal chemistry letters.

[7]  Roberto Pellicciari,et al.  Structural basis for bile acid binding and activation of the nuclear receptor FXR. , 2003, Molecular cell.

[8]  S. Kliewer,et al.  Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Kliewer,et al.  Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. , 2002, Molecular pharmacology.

[10]  S. Wright,et al.  Lithocholic Acid Decreases Expression of Bile Salt Export Pump through Farnesoid X Receptor Antagonist Activity* , 2002, The Journal of Biological Chemistry.

[11]  J. Chiang,et al.  Bile acid regulation of gene expression: roles of nuclear hormone receptors. , 2002, Endocrine reviews.

[12]  T. Willson,et al.  6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. , 2002, Journal of medicinal chemistry.

[13]  D. Russell,et al.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.

[14]  M. Karin,et al.  Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.

[15]  A. Halabi,et al.  Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole. , 2002, British journal of clinical pharmacology.

[16]  J. Wallace,et al.  A NO‐releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway 
THIS ARTICLE HAS BEEN RETRACTED , 2002, British journal of pharmacology.

[17]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[18]  G. Gil,et al.  Suppression of sterol 12alpha-hydroxylase transcription by the short heterodimer partner: insights into the repression mechanism. , 2001, Nucleic acids research.

[19]  M. Makishima,et al.  Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.

[20]  M. Makishima,et al.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.

[21]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[22]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[23]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[24]  D. Meijer,et al.  Mrp2 is essential for estradiol‐17β(β‐D ‐glucuronide)–induced cholestasis in rats , 2000 .

[25]  P. Meier,et al.  Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. , 2000, Gastroenterology.

[26]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[27]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[28]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[29]  Richard J. Thompson,et al.  A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis , 1998, Nature Genetics.

[30]  R. Hammer,et al.  Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα , 1998, Cell.

[31]  M. Kool,et al.  A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome , 1997, Hepatology.

[32]  C. Gartung,et al.  Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. , 1996, The American journal of physiology.

[33]  Jasmine Chen,et al.  Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.

[34]  P. Meier,et al.  In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. , 1994, Gastroenterology.

[35]  P. Meier,et al.  Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. , 1993, The Journal of clinical investigation.

[36]  D. Russell,et al.  Bile acid biosynthesis. , 1992, Biochemistry.

[37]  M. Vore.  Estrogen cholestasis. Membranes, metabolites, or receptors? , 1987, Gastroenterology.

[38]  J. Sjövall,et al.  Effect of ethynylestradiol on biliary excretion of bile acids, phosphatidylcolines, and cholesterol in the bile fistula rat. , 1977, Journal of lipid research.

[39]  Bruno Stieger,et al.  Enterohepatic bile salt transporters in normal physiology and liver disease. , 2004, Gastroenterology.

[40]  M. Evans,et al.  Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. , 2003, The Journal of biological chemistry.

[41]  F. Kuipers,et al.  Differential effects of 17alpha-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat. , 1999, Journal of lipid research.

[42]  K. Setchell,et al.  Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. , 1997, Gastroenterology.

[43]  D. Moore,et al.  Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.